close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sydnexis, Inc.

News headline image
Sydnexis Announces FDA Advisory Committee Meeting to Review NDA for SYD-101 for Pediatric Progressive Myopia
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis to Present New Data from Phase 3 STAR Trial of SYD-101 at ARVO 2026 Annual Meeting
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces New Data from Phase 3 STAR Trial of SYD-101 Presented at 2026 AAPOS Annual Meeting
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces UK Approval of Ryjunea® by Partner Santen to Slow Progression of Childhood Myopia
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Receives Complete Response Letter from FDA for SYD-101 to Slow Pediatric Myopia Progression
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces European Commission Approval of SYD-101, the First and Only Pharmaceutical Treatment for Slowing the Progression of Pediatric Myopia
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces Three Abstracts Accepted for Poster Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces Positive CHMP Opinion in Europe for SYD-101 for Slowing the Progression of Pediatric Myopia
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Announces FDA Acceptance of New Drug Application for SYD-101 for the Treatment of Progression of Pediatric Myopia
From Sydnexis, Inc.
Via Business Wire
News headline image
Perry J. Sternberg Joins Sydnexis as Chief Executive Officer
From Sydnexis, Inc.
Via Business Wire
News headline image
Sydnexis Secures $45 Million Series B Financing Led by Visionary Ventures and Blue Stem Capital
From Sydnexis, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.